Related Experiment Video
Updated: May 11, 2026

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice
William L Holland1, Andrew C Adams, Joseph T Brozinick
1Touchstone Diabetes Center, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390-8549, USA.
Abstract:
FGF21, a member of the fibroblast growth factor (FGF) superfamily, has recently emerged as a regulator of metabolism and energy utilization. However, the exact mechanism(s) whereby FGF21 mediates its actions have not been elucidated. There is considerable evidence that insulin resistance may arise from aberrant accumulation of intracellular lipids in insulin-responsive tissues due to lipotoxicity. In particular, the sphingolipid ceramide has been implicated in this process. Here, we show that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals. Importantly, adiponectin-knockout mice are refractory to changes in energy expenditure and ceramide-lowering effects evoked by FGF21 administration. Moreover, FGF21 lowers blood glucose levels and enhances insulin sensitivity in diabetic Lep(ob/ob) mice and diet-induced obese (DIO) mice only when adiponectin is functionally present. Collectively, these data suggest that FGF21 is a potent regulator of adiponectin secretion and that FGF21 critically depends on adiponectin to exert its glycemic and insulin sensitizing effects.
Insights
Fibroblast growth factor 21 (FGF21) regulates metabolism by stimulating adiponectin secretion. This action is crucial for FGF21 to improve energy expenditure, lower ceramide levels, and enhance insulin sensitivity in obese mice.
Area of Science:
- Metabolic regulation
- Endocrinology
- Lipid metabolism
Background:
- Fibroblast growth factor 21 (FGF21) is a key metabolic regulator.
- Insulin resistance is linked to intracellular lipid accumulation and ceramide buildup.
- The precise mechanisms of FGF21 action remain unclear.
Purpose of the Study:
- To investigate the role of adiponectin in mediating FGF21's metabolic effects.
- To determine if adiponectin is essential for FGF21 to improve insulin sensitivity and energy expenditure.
Main Methods:
- Administered FGF21 to wild-type and adiponectin-knockout mice.
- Assessed changes in adiponectin secretion, energy expenditure, ceramide levels, and blood glucose.
- Utilized diabetic Lep(ob/ob) and diet-induced obese (DIO) mouse models.
Main Results:
- FGF21 significantly increased adiponectin secretion and reduced ceramide accumulation in obese rodents.
- Adiponectin-knockout mice did not exhibit FGF21-induced improvements in energy expenditure or ceramide reduction.
- FGF21's glucose-lowering and insulin-sensitizing effects were dependent on the presence of functional adiponectin.
Conclusions:
- FGF21 is a potent stimulator of adiponectin secretion.
- Adiponectin is critical for FGF21 to exert its beneficial effects on glycemic control and insulin sensitivity.
More Related Videos
Related Concept Videos
Regulation of Food Intake
Regulation of Metabolism

